Search research articles
Contact Us
Filters
Showing results (11-20 of 29) with videos related to
Page
of 3
Sort By:
Nature Medicine
|
July 4, 2001
CD4+ T-cell-epitope escape mutant virus selected in vivo
A Ciurea, L Hunziker, M M Martinic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 2000
Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design
A F Ochsenbein, D D Pinschewer, B Odermatt, et al.
Zeitschrift Fur Rheumatologie
|
June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]
M Distler, J Distler, A Ciurea, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study
L Brulhart, A Ciurea, A Finckh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
A Ciurea, P Klenerman, L Hunziker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Viral persistence in vivo through selection of neutralizing antibody-escape variants
A Ciurea, P Klenerman, L Hunziker, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 18, 2002
Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase
D Gavriliu, C Fossey, A Ciurea, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 3, 2001
Synthesis of 5-alkenylated D4T analogues via the Pd-catalyzed cross-coupling reaction
A Ciurea, C Fossey, S Benzaria, et al.
Annals of the Rheumatic Diseases
|
May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
A Finckh, A Ciurea, L Brulhart, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2005
Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors
A Ciurea, C Fossey, D Gavriliu, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 29) with videos related to
Sort By:
Page
of 3
Nature Medicine
|
July 4, 2001
CD4+ T-cell-epitope escape mutant virus selected in vivo
A Ciurea, L Hunziker, M M Martinic, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
June 8, 2000
Correlation of T cell independence of antibody responses with antigen dose reaching secondary lymphoid organs: implications for splenectomized patients and vaccine design
A F Ochsenbein, D D Pinschewer, B Odermatt, et al.
Zeitschrift Fur Rheumatologie
|
June 29, 2006
[Evidence-based therapy of Raynaud's syndrome]
M Distler, J Distler, A Ciurea, et al.
Annals of the Rheumatic Diseases
|
March 17, 2006
Efficacy of B cell depletion in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor alpha agents: an open-label observational study
L Brulhart, A Ciurea, A Finckh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 16, 1999
Persistence of lymphocytic choriomeningitis virus at very low levels in immune mice
A Ciurea, P Klenerman, L Hunziker, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 26, 2000
Viral persistence in vivo through selection of neutralizing antibody-escape variants
A Ciurea, P Klenerman, L Hunziker, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
December 18, 2002
Synthesis and anti-HIV activity of [d4U]-[trovirdine analogue] and [d4T]-[trovirdine analogue] heterodimers as inhibitors of HIV-1 reverse transcriptase
D Gavriliu, C Fossey, A Ciurea, et al.
Nucleosides, Nucleotides & Nucleic Acids
|
October 3, 2001
Synthesis of 5-alkenylated D4T analogues via the Pd-catalyzed cross-coupling reaction
A Ciurea, C Fossey, S Benzaria, et al.
Annals of the Rheumatic Diseases
|
May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
A Finckh, A Ciurea, L Brulhart, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry
|
January 25, 2005
Synthesis of 5-alkynylated d4T analogues as potential HIV-1 reverse transcriptase inhibitors
A Ciurea, C Fossey, D Gavriliu, et al.
Page
of 3